Dengue and dengue hemorrhagic fever in the Americas: Lessons and challenges

Journal of Clinical Virology

Volumn 27, Issue 1, 2003, Pages 1-13

  Guzman, María G ^a   Kouri, Gustavo ^a  

^a INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

Author keywords

Dengue; Dengue hemorrhagic fever; The Americas

Indexed keywords

AGE DISTRIBUTION; CLINICAL FEATURE; DENGUE; DENGUE VIRUS; DISEASE COURSE; ENVIRONMENTAL SANITATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; ETHNIC DIFFERENCE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; MORTALITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEROTYPE; SOUTH AND CENTRAL AMERICA; SOUTHEAST ASIA; SUPERINFECTION; URBANIZATION; VIRUS PATHOGENESIS; VIRUS TRANSMISSION; YELLOW FEVER;

EID: 0037408183     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(03)00010-6     Document Type: Review

References (83)

1. Almond J., Clemens J., Engers H., Halstead S., Khiem H., Pablos-Mendez A., Pervikov Y., Tram T. Accelerating the development and introduction of a dengue vaccine for poor children, 5-8 December, 2001 Ho Chi Minh City, VietNam. Vaccine. 20:2002;3043.
2. Anderson C.R., Downs W.G., Hill A.E. Isolation of dengue virus from a human being in Trinidad. Science. 124:1956;224-225.
3. Ballester JM. Fiebre hemorragica por dengue. Aspectos hematologicos e inmunologicos. Editorial Ciencias Medicas. Ciudad Habana, 1986.
4. Bravo J.R., Guzman M.G., Kouri G.P. Why dengue haemorrhagic fever in Cuba?: 1: Individual risk factors for dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS). Trans. R. Soc. Trop. Med. Hyg. 81:1987;816-820.
5. Burke D.S., Nisalak A., Johnson D., Scott M. A prospective study of dengue virus infection in Bangkok. Am. J. Trop. Med. Hyg. 38:1988;172-180.
6. CDC, Dengue and dengue hemorrhagic fever in the Americas, MMWR 1986a;37:129-31.
7. CDC, Aedes albopictus infestation - United States, Brazil. MMWR 1986b;35:493-95.
8. Chiewsilp P. Histocompatibility antigens and dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 30:1981;1100.
9. Clark G.G. Situación epidemiológica del dengue en América. Desafíos para su vigilancia y control. Rev. Salud Pública México. 37:1995;S5-S10.
10. Diaz A., Kouri G., Guzman M.G., Lobaina L., Bravo J., Ruiz A., Ramos A., Martinez R. Description of the clinical picture of dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) in adults. Bull. Pan Am. Health Organ. 22:1988;133-144.
11. Ehrenkranz N.J., Ventura A.K., Cuadrado R.R., Pond W.L., Porter J.E. Panedmic dengue in Caribbean countries and the southern United Sates - past, present and potential problems. New Engl. J. Med. 285:1971;1460-1469.
12. Figueroa R., Ramos C. Dengue virus (serotype 3) circulation in endemic countries and its reappearance in America. Arch. Med. Res. 31:2000;429-430.
13. Fisher D.B., Halstead S.B. Observations related to pathogenesis of dengue hemorrhagic fever. V Examination of age specific sequential infection rates using a mathematical model. Yale J. Biol. Med. 42:1970;329-349.
14. Green D. Faces of Latin America. 1997;Latin American Bureau, London, UK.
15. Gubler D.J. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol. 2:2002;100-103.
16. Gubler D.J. Gubler D.J., Kuno G. Dengue and Dengue Hemorrhagic Fever: Its History and Resurgence as a Global Public Health Problem. 1997;1-22 CAB International, New York.
17. Gubler D.J. Surveillance for dengue and dengue hemorrhagic fever. PAHO Bull. 23:1989;397-404.
18. Guzman M.G., Kouri G., Valdes L., Bravo J., Vazquez S., Halstead S.B. Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks. Pan Am. J. Public Health. 11:2002;223-227.
19. Guzman M.G., Kouri G., Bravo J., Valdes L., Vazquez S., Halstead S.B. Effect of age outcome of secondary dengue 2 infections. Int. J. Infect. Dis. 6:2002;118-124.
20. Guzman M.G., Kouri G. Dengue: an update. Lancet. 2:2002;33-42.
21. Guzman M.G., Kouri G., Valdes L., Bravo J., Alvarez M., Vazquez S., Delgado I., Halstead S.B. Epidemiological studies on dengue in Santiago de Cuba 1997. Am. J. Epidemiol. 152:2000;793-799.
22. Guzman M.G., Alvarez M., Rodriguez R., Rosario D., Vazquez S., Valdes L., Cabrera M.V., Kouri G. Fatal dengue haemorrhagic fever in Cuba 1997. Int. J. Infect. Dis. 3:1999;130-135.
23. Guzman M.G., Huelva G., Saenz E., Quiroz E., de los Reyes J., Balmaseda A., Gonzalez A., Kouri G. Reintroducción del dengue 3 en las Américas: 1994-1996. Arch. Venezolanos Med. Trop. 2:1998;8-19.
24. Guzman M.G., Vazquez S., Martinez E., Alvarez M., Rodriguez R., Kouri G., Reyes J., Acevedo F. Dengue in Nicaragua, 1994: reintroduction of serotype 3 in the Americas. Pan Am. J. Public Health. 1:1996;193-199.
25. Guzman M.G., Deubel V., Pelegrino J.L., Rosario D., Marrero M., Sariol C., Kouri G. Partial nucleotide and amino acid sequences of the envelope and the envelope/nonstructural protein-1 gene junction of four dengue-2 virus strains isolated during the 1981 Cuban epidemic. Am. J. Trop. Med. Hyg. 52:1995;241-246.
26. Guzman M.G., Kouri, Bravo J., Soler M., Vazquez S., Morier L. Dengue hemorrhagic in Cuba 1981: a retrospective seroepidemiologic study. Am. J. Trop. Med. Hyg. 42:1990;179-184.
27. Guzman M.G., Kouri G., Martinez E., Bravo J., Riveron R., Soler M., Vazquez S., Morier L. Clinical and serologic study of Cuban children with dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS). Bull. Pan Am. Organ. 2:1987;270-279.
28. Guzman M.G., Kouri G., Morier L., Fernandez A. A study of fatal haemorrhagic dengue cases in Cuba 1981. Bull. PAHO. 18:1984;213-220.
29. Halstead S.B., Streit T.G., Lafontant J.G., Putvatana R., Russell K., Sun Wellington, Kanesa-Thasan N., Hayes C.G., Watts D.M. Haiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission. Am. J. Trop. Med. Hyg. 65:2001;180-183.
30. Halstead S.B. Antibody-Dependent Enhancement of Infection: A Mechanism for Indirect Virus Entry into Cells. Cellular Receptors for Animal Viruses. 1994;493-516 Cold Spring Harbor Laboratory Press.
31. Halstead S. Pathophysiology and pathogenesis of dengue hemorrhagic fever, In: Thongcharoen P, editor. World Health Organization, Regional Publication SEARO. No. 22 1993. p. 80-103.
32. Halstead S.B. The pathogenesis of Dengue. Molecular epidemiology in infectious disease. Am. J. Epidemiol. 114:1981;632-648.
33. Halstead S.B., O'Rourke E.J. Dengue viruses and mononuclear phagocytes. I Infection enhancement by non-neutralizing antibody. J. Exp. Med. 146:1977;210-217.
34. Harris E., Videa E., Perez E., Sandoval E., Tellez Y., Perez M.A., Cuadra R., Rocha J., Idiaquez W., Alonso R.E., Delgado M.A., Campo L.A., Acevedo F., Gonzalez A., Amador J.J., Balmaseda A. Clinical, epidemiologic and virologic features of dengue in the 1998 epidemic in Nicaragua. Am. J. Trop. Med. Hyg. 63:2000;5-11.
35. Kanesa-thaan, Sun W., Kim-Ahn G., Van Albert S., Putnak J.R., King A., Raengsakulsrach B., Christ-Schmidt H., Gilson K., Zahradnik J.M., Vaughn D.W., Innis B.L., Saluzzo J.F., Hoke C.H. Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers. Vaccine. 19:2001;3179-3188.
36. Kochel T.J., Watts D.M., Halstead S.B., Hayes C.G., Espinoza A., Felices V., Caceda R., Bautista C.T., Montoya Y., Douglas S., Russell K.L. Effect of dengue 1 antibodies on american dengue 2 viral infection and dengue haemorrhagic fever. Lancet. 360:(9329):2002;310-312.
37. Kouri G., Guzman M.G., Valdes L., Carbonell I., Rosario D., Vázquez S., Laferte J., Delgado J., Cabrera M.V. Reemergence of Dengue in Cuba: a 1997 epidemic in Santiago de Cuba. Emerg. Infect. Dis. 1:1998;89-92.
38. Kouri G.P., Guzman M.G., Bravo J.R. Why dengue haemorrhagic fever in Cuba? 2: An integral analysis. Trans. R. Soc. Trop. Med. Hyg. 81:1987;821-823.
39. Kouri G.P., Guzman M.G., Bravo J.R., Triana C. Dengue hemorrhagic fever/dengue shock syndrome: lessons from the Cuban epidemic, 1981. Bull. World Health Organ. 67:1989;375-380.
40. Kurane I., Takasaki T. Dengue fever and dengue haemorrhagic fever: challenges of controlling an enemy still at large. Rev. Med. Virol. 11:2001;301-311.
41. Kurane I., Ennis F.A. Cytokines in dengue virus infections: role of cytokines in the pathogenesis of dengue hemorrhagic fever. Semin. Virol. 5:1994;443-448.
42. Kurane I., Innis B.L., Nimmannitya S., Nisalak A., Meager A., Janus J., Ennis F.A. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin-2 receptor, soluble CD4, soluble CD8, interleukin 2 and interferon-γ in sera of children with dengue. J. Clin. Invest. 88:1991;1473-1480.
43. Kurane I., Mady B.J., Ennis F.A. Antibody-dependent enhancement of dengue virus infection. Rev. Med. Virol. 1:1991;211-221.
44. LaFleur C., Granados J., Vargas-Alarcon G., Ruiz-Morales J., Villareal-Garza C., Higuera L., Hernandez-Pacheco G., Cutiño-Moguel T., Rangel H., Figueroa R., Acosta M., Lazcano E., Ramos C. HLA-DR antigen frequencies in mexican patients with dengue virus infection: HLA-DR4 as a possible genetic resistance factor for dengue hemorrhagic fever. Hum. Immunol. 63:2002;1039.
45. Lanciotti R.S., Lewis J.G., Gubler D.J., Trent D.W. Molecular evolution and epidemiology of dengue 3 viruses. J. Gen. Virol. 75:1994;65-75.
46. Leitmeyer K.C., Vaughn D.W., Watts D.M., Salas R., Villalobos I., Ramos C., Rico-Hesse R. Dengue virus structural differences that correlate with pathogenesis. J. Virol. 73:1999;4738-4747.
47. Loke H., Bethell D.B., Phuong C.X.T., Dung M., Schneider J., White N.J., Day N.P., Farrar J., Hill A.V.S. Strong HLA class I-restricted T cell responses in dengue hemorrhagic fever: a double-edged sword. J. Infect. Dis. 184:2001;1369-1373.
48. Mas P. Dengue fever in Cuba in 1977: some laboratory aspects, In: Dengue in the Caribbean, 1977. Pan American Health Organization. Scientific Publication, No. 375, 1979.
49. Miagostovich M.P., Santos F.B., Simone T.S., Costa E.V., Filippis A.M., Schatzmayr H.G., Nogueira R.M. Genetic characterization of dengue virus type 3 isolates in the State of Rio de Janeiro, 2001. Braz. J. Med. Biol. Res. 35:2002;869-872.
50. MMWR. Dengue type 3 infection - Nicaragua and Panamá, October-November, 1994. 1995;44,21-24.
51. Monath T.P. Yellow fever and dengue - the interactions of virus, vector and host in the re-emergence of epidemic disease. Semin. Virol. 5:1994;133-145.
52. Nimmannitya S. Clinical manifestations of dengue/dengue haemorrhagic fever. Monograph on dengue/dengue haemorrhagic fever. World Health Organization. Regional Office for South-East Asia, New Delhi, Regional Publication, SEARO No. 22, 1993.
53. Nimmannitya S., Halstead S.B., Cohen S.N., Margiotta R.R. Dengue and chikungunya virus infection in man in Thailand 1962-1964. Observations on hospitalized patients with haemorrhagic fever. Am. J. Trop. Med. Hyg. 18:1969;954-971.
54. Organización Panamericana de la Salud. Nueva Generación de Programas de Prevención y Control del Dengue en las Américas. OPS/HCP/HCT/206/02.
55. Organización Panamericana de la Salud. Report of meeting of dengue laboratories in the Americas. Rio de Janeiro, Brazil, October 8, 1996. PAHO/HCP/HCT/93/97.
56. PAHO. Dengue fever in Costa Rica and Panama. Epidemiological Bull 1994;15,9-10.
57. PAHO. Dengue en las Américas. Una actualización. Bol Epidemiol 1993;14,1-3.
58. PAHO. Dengue and Dengue haemorrhagic fever in the americas: an overview of the problem. Epidemiol. Bull, 1992;13,12.
59. PAHO. Dengue haemorrhagic fever in Venezuela. Epidimiol Bull 1990;11,7-9.
60. Pan American Health Organization. Dengue and dengue hemorrhagic fever in the Americas: Guidelines for Prevention and Control. Scientific Publication No. 548, 1994.
61. PAHO. Dengue and dengue haemorrhagic fever in the Americas: an overview of the problem. Epidemiol. Bull 1992;13,1-2.
62. Pinheiro F.P., Corber S.J. Global situation of dengue and dengue haemorrhagic fever, adn its emergence in the Americas. World Health Stat. Q. 50:1997;161-169.
63. Pinheiro F.P. Dengue in the Americas 1980-1987. Epidemiol. Bull. PAHO. 10:1989;1-8.
64. Pittaluga G. Sobre un brote de dengue en la Habana. Rev. Med. Trop. Paras bact Clin. Lab. 11:1945;66.
65. Rico-Hesse R., Harrison L.M., Salas R.A., Tovar D., Nisalak A., Ramos C., Boshell J., Mesa M.T.R., Nogueira R.M.R., Rosa A.T.D. Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology. 230:1997;244-251.
66. Rigau J. Puerto Rico Association of Epidemiologists. Clinical manifestations of dengue haemorrhagic fever in Puerto Rico. Pan. Am. J. Public Health. 1:1997;381-388.
67. Rocco I.M., Kavakama B.B., Santos C.L. First isolation of dengue 3 in Brazil from an imported case. Rev. Inst. Med. Trop. Sao Paulo. 43:2001;55-57.
68. Rosen L. Observations on the epidemiology of dengue in Panama. Am. J. Hyg. 68:1958;45-58.
69. Rothman A.L., Ennis F.A. Minireview. Immunopathogenesis of dengue hemorrhagic fever. Virology. 257:1999;1-6.
70. Rothman A.L., Ennis F.A. Cunningham M.W., Fujinami R.S. Toga/Flaviviruses: Immunopathology. 2000;473-487 Lippincott Williams & Wilkins, Philadelphia.
71. Rothman A.L., Kanesa-thasan N., West K., Janus J., Saluzzo J.F., Ennis F.A. Induction of T lymphocyte responses to dengue virus by a candidate tetravalent live attenuated dengue virus vaccine. Vaccine. 19:2001;4694-4699.
72. Rush AB. An account of the bilious remitting fever, as it appeared in Philadelphia in the summer and autumn of the year 1780. Medical Inquiries and Observations. Prichard and Hall, Philadelphia, 1789;pp. 104-17.
73. Sangkawibha N., Rojanasuphot S., Ahandrik S., Viriyapongse S., Jatanasen S., Salitul V., Phanthumachinda B., Halstead S.B. Risk factors in Dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. Am. J. Epidemiol. 120:1984;653-669.
74. Sariol C., Pelegrino J.L., Martinez A., Arteaga E., Kouri G., Guzman M.G. Detection and genetic relationship in 17-year old paraffin embedded samples of Cuba. Am. J. Trop. Med. Hyg. 61:1999;994-1000.
75. Schleissman D.J., Calheiros L.B. A review of the status of yellow fever and Aedes aegypti eraqdication programs in the Americas. Mosq. News. 34:1974;1-9.
76. Sierra B., Garcia G., Perez Ana B., Morier L., Rodriguez R., Alvarez M., Guzman M.G. Long term memory cellular immune responde to dengue virus after a natural primary infection. Int. J. Infect. Dis. 6:2002;125-128.
77. The International Bank for Reconstruction and Development. World Development Indicators 2001. Washington, DC.: The World Bank, 2001.
78. The World Health Report 1998. Life in the 21st century. A vision for all. World Health Organization, Geneva, 1998.
79. Valdes L., Vila J., Guzman M.G.@ Impacto economico de la epidemia de dengue 2 de Santiago de Cuba, 1997, Rev Cubana Med Trop, 2002, 54, in press.
80. Wali J.P., Biswas A., Handa R., Aggarwal P., Wig N., Dwivedi S.N. Dengue haemorrhagic fever in adults: a prospective study of 110 cases. Trop. Doct. 29:1999;27-30.
81. Watts D.M., Porter K.R., Putvatana P., Vasquez B., Calampa C., Hayes C., Halstead S.B. Failure of secondary infection with American genotype dengue 2 to cause dengue hemorrhagic fever. Lancet. 354:1999;1431-1433.
82. World Health Organization. Strengthening implementation of the global strategy for Dengue Fever and Dengue Haemorrhagic Fever, prevention and control. Report of the Informal Consultation, 18-20 October 1999, WHO HQ, Geneva.
83. Zagne S.M.O., Alves V.G.F., Nogueira R.M.R., Miagostovich M.P., Lampe E., Tavares W. Dengue hemorrhagic fever in the state of Rio de Janeiro, Brazil: a study of 56 confirmed cases. Trans. R. Soc. Trop. Med. Hyg. 88:1994;677-679.